TCM
CAPR icon

Tang Capital Management’s Capricor Therapeutics CAPR Stock Holding History

Tang Capital Management’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$103M Buy
3,399,900
+1,699,900
+100% +$45.3M 5.25% 7
2025
Q4 		$49.1M Buy
+1,700,000
New +$22.2M 2.42% 15
2025
Q2 		– Sell
-79,100
Closed -$751K – 206
2025
Q1 		$751K Buy
+79,100
New +$1.1M 0.04% 171

Other funds holding CAPR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tang Capital Management's CAPR Position: Q1 2026 in Review

Tang Capital Management increased its Capricor Therapeutics (CAPR) stake by 100% in Q1 2026, buying an estimated $45.3M and bringing the position to 3,399,900 shares worth $103M. The position accounts for 5.25% of the portfolio, ranked #7.

Tang Capital Management first reported a position in CAPR in Q1 2025 and has held it in 3 quarters since. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • Tang Capital Management held 3,399,900 shares of Capricor Therapeutics worth $103M as of Q1 2026.
  • Tang Capital Management bought 1,699,900 Capricor Therapeutics shares in Q1 2026, an estimated $45.3M.
  • Capricor Therapeutics made up 5.25% of Tang Capital Management's portfolio in Q1 2026, its #7 holding.
  • Tang Capital Management first reported a position in Capricor Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on Tang Capital Management's 13F filing for Q1 2026, filed 15 May 2026.